The latest cancer drugs news
Browsing: Cancer Drug News
FDA approves nivolumab for oesophageal squamous cell carcinoma
The Food and Drug Administration (FDA) approved nivolumab for patients with unresectable advanced, recurrent or…
Leukaemia immune profiles predict drug resistance and benefits of immunotherapy
By analysing 442 samples from three groups of children and adults with acute myeloid leukaemia…
ASCO 2020: Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS
The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol…
ASCO 2020: Researchers underscore efficacy of pembrolizumab plus axitinib in treating advanced renal cell carcinoma
Researchers at Fox Chase Cancer Center, USA, along with an international team of investigators, have…
ASCO 2020: Pembrolizumab doubles time to disease progression in patients with advanced colorectal cancer with specific DNA mutations
Front-line therapy with the immune checkpoint inhibitor pembrolizumab doubled progression-free survival vs chemotherapy in patients…
ASCO 2020: Post-surgery osimertinib delays disease recurrence in patients with localised non-small cell lung cancer
Treatment with targeted therapy osimertinib following surgery for localised non-small cell lung cancer (NSCLC) with…
New drug combinations help overcome resistance to immunotherapy
A study from researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, helps explain how…
Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed
This content is password-protected. To view it, please enter the password below. Password:
Anti-malarial drug shows promise for brain cancer treatment
Glioblastoma multiforme (GBM) is an aggressive form of cancer in the brain that is typically…
High cost of new cancer drugs in US not related to their effectiveness, study shows
The high costs of recently licensed cancer medicines in the United States—as compared with those…